Anixa Biosciences is trading 8% higher at $3.62, up from the August 31 close of $3.35, with no clear company-specific announcement or overnight filing explaining the September 1, 2026, pre-market move.
- Latest identified company news is an August 24 conference presentation announcement.
- Estimated earnings are scheduled for September 9.
- Broader market sentiment is cautious, while major indices are moving in different directions.